Results 21 to 30 of about 517,223 (251)
Immunity, Inflammation and Disease, 2023 The aim of this cross‐sectional study was to compare the levels of inflammatory mediators in nasal secretions in patients with aspirin‐exacerbated respiratory disease (AERD) and in those with nasal polyposis (NP) without aspirin‐sensitivity and to ...
A. Perić +3 more
semanticscholar +1 more source
Recurrent sinonasal polyposis after the endoscopic sinus surgery [PDF]
Reviews in Clinical Medicine, 2014 Nasal polyposis is one of the chronic airway diseases, which affects the patient’s quality of life in different ways. There are various complications along with nasal polyposis, which might be cured by drug administration.
Fereshteh Esmatinia, Mahdi bakhshaei
doaj +3 more sources
International Forum of Allergy and Rhinology, 2022 Comparative effectiveness research between endoscopic sinus surgery (ESS) and biologic therapy for severe chronic rhinosinusitis with nasal polyposis (CRSwNP) is a nascent field as new therapeutic modalities become clinically available.
Amar Miglani +4 more
semanticscholar +1 more source
Evaluation of BRAF and KRAS Gene Expression in Nasal Polyposis. [PDF]
Turk Arch OtorhinolaryngolObjective: The goal of this study was to investigate the expression patterns and potential relationship of the Kirsten rat sarcoma viral oncogene homolog (KRAS) and B-raf proto-oncogene (BRAF) genes in nasal polyposis (NP). Methods: Twenty-nine patients
Özbilen Acar G +4 more
europepmc +2 more sources
Allergy. European Journal of Allergy and Clinical Immunology, 2021 Clinically meaningful improvement in the Sino‐Nasal Outcome Test‐22 (SNOT‐22) was observed in patients with severe, eosinophilic asthma, and nasal polyposis (NP) treated with benralizumab in the ANDHI trial.
G. Canonica +9 more
semanticscholar +1 more source
IL-13–associated epithelial remodeling correlates with clinical severity in nasal polyposis
medRxiv, 2022 Background: Epithelial remodeling is a histopathologic feature of chronic inflammatory airway diseases including chronic rhinosinusitis (CRS). Cell type shifts and their relationship to CRS endotypes and severity are incompletely described.
M. Kotas +8 more
semanticscholar +1 more source
25-Hydroxyl Vitamin D Deficiency in Nasal Polyposis
International Archives of Otorhinolaryngology, 2020 Introduction Vitamin D is known to have immunomodulatory functions and has action on chronic inflammatory processes, such as nasal polyposis. Objective The present study assessed the levels of 25-hydroxy vitamin D and high-sensitivity C ...
Ankur Kumar Chandrakar +4 more
doaj +1 more source
The Laryngoscope, 2021 Clinical trials of biologics to treat chronic rhinosinusitis with nasal polyposis (CRSwNP) have evaluated objective outcomes (e.g., University of Pennsylvania Smell Identification Test [UPSIT], nasal polyps score [NPS], and computed tomography Lund ...
Joseph K. Han +16 more
semanticscholar +1 more source
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.
Journal of Allergy and Clinical Immunology, 2021 BACKGROUND Chronic rhinosinusitis with nasal polyps (CRSwNP) frequently remains uncontrolled despite maximal medical therapy and sinonasal surgery, presenting several unmet needs and challenges.
P. Gevaert +13 more
semanticscholar +1 more source
Pathogenesis of nasal polyposis [PDF]
Clinical & Experimental Allergy, 2015 Summary Chronic rhinosinusitis with nasal polyps ( CRS w NP ) is a complex inflammatory condition that affects a large proportion of the population world‐wide and is associated with high cost of management and significant morbidity ...
K E, Hulse +3 more
openaire +2 more sources